ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thiadens, H.
Right arrow Articles by Postma, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thiadens, H.
Right arrow Articles by Postma, D.
Eur Respir J 1998; 12: 842-847
Copyright © ERS Journals Ltd 1998


Clinical Trial

Value of measuring diurnal peak flow variability in the recognition of asthma: a study in general practice

HA Thiadens, GH De Bock, FW Dekker, JA Huysman, JC Van Houwelingen, MP Springer, and DS Postma

In this study we analysed the value of measuring diurnal peak flow variability (DPV) in general practice for diagnosing asthma or chronic obstructive pulmonary disease (COPD). One hundred and eighty-two subjects, aged 18-75 yrs, with undiagnosed asthma or COPD, presenting with a persistent cough recorded a peak flow diary twice daily for 2 weeks. A diagnosis of asthma or COPD was based on the recurrence of airway symptoms in the past year accompanied by spirometric measurements and a provocative dose of methacholine causing a 20% fall in forced expiratory volume in one second. DPV was expressed as amplitude percentage highest of the day. Cut-off values of 15% and 20% (DPV15%, DPV20%) were employed and the number of days that these values were reached, was assessed. The influence of age, sex and pack-years smoking on DPV was analysed by logistic regression. The a priori probability to have asthma (n=69) or COPD (n=12) was 45% (81/182) and increased to >70% with a DPV20% for at least 3, and a DPV15% for at least 4 days. Scoring formulas for asthma (DPV15% (number of days present) + 4 (if female sex)) and for asthma and COPD combined (8x DPV15% (number of days present) + 24 (if female sex) + pack-years smoking) predicted which subjects were at risk for having asthma (or COPD). Simple formulas based on the number of days with diurnal peak flow variability at 15%, female sex and pack-years can predict which patients with persistent cough are likely to have asthma or chronic obstructive pulmonary disease.


This article has been cited by other articles:


Home page
ThoraxHome page
M R Miller
The PEF data plot: planning to get the message
Thorax, February 1, 2005; 60(2): 91 - 92.
[Full Text] [PDF]


Home page
ChestHome page
C. A. Holcroft, E. A. Eisen, S. R. Sama, and D. H. Wegman
Measurement Characteristics of Peak Expiratory Flow
Chest, August 1, 2003; 124(2): 501 - 510.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.R. Miller, T. Sigsgaard, O. Omland, and O.F. Pedersen
Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking
Eur. Respir. J., July 1, 2002; 20(1): 86 - 91.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. L. Enright, R. L. McClelland, A. S. Buist, and M. D. Lebowitz
Correlates of Peak Expiratory Flow Lability in Elderly Persons
Chest, December 1, 2001; 120(6): 1861 - 1868.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H A Thiadens, G H De Bock, J C Van Houwelingen, F W Dekker, M W M De Waal, M P Springer, and D S Postma
Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV1 in primary care patients presenting with a persistent cough?
Thorax, December 1, 1999; 54(12): 1055 - 1060.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. KÜNZLI, E. Z. STUTZ, A. P. PERRUCHOUD, O. BRÄNDLI, J.-M. TSCHOPP, G. BOLOGNINI, W. KARRER, C. SCHINDLER, U. ACKERMANN-LIEBRICH, and P. LEUENBERGER
Peak Flow Variability in the SAPALDIA Study and Its Validity in Screening for Asthma-related Conditions
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 427 - 434.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.